Jonathon Unwin
Stock Analyst at Barclays
(0.16)
# 4,219
Out of 4,334 analysts
50
Total ratings
16%
Success rate
-23.1%
Average return
Main Sectors:
Stocks Rated by Jonathon Unwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: YPSN Ypsomed Holding AG | Maintained: Buy | $343 → $386 | $340.00 | +13.53% | 5 | May 21, 2026 | |
| ETR: AFX Carl Zeiss Meditec AG | Rated: Hold | $30 → $28 | $26.50 | +5.66% | 9 | May 13, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Maintained: Hold | $16 | $16.90 | -5.33% | 12 | May 13, 2026 | |
| ETR: GXI Gerresheimer AG | Downgraded: Sell | $23 → $19 | $27.00 | -29.63% | 7 | Apr 28, 2026 | |
| STO: VIMIAN Vimian Group AB (publ) | Maintained: Sell | $25 | $28.85 | -13.34% | 11 | Mar 27, 2026 | |
| LON: ONT Oxford Nanopore Technologies plc | Maintained: Buy | $1.7 → $1.72 | $129.40 | -98.67% | 6 | Mar 25, 2026 |
Ypsomed Holding AG
May 21, 2026
Maintained: Buy
Price Target: $343 → $386
Current: $340.00
Upside: +13.53%
Carl Zeiss Meditec AG
May 13, 2026
Rated: Hold
Price Target: $30 → $28
Current: $26.50
Upside: +5.66%
SCHOTT Pharma AG & Co. KGaA
May 13, 2026
Maintained: Hold
Price Target: $16
Current: $16.90
Upside: -5.33%
Gerresheimer AG
Apr 28, 2026
Downgraded: Sell
Price Target: $23 → $19
Current: $27.00
Upside: -29.63%
Vimian Group AB (publ)
Mar 27, 2026
Maintained: Sell
Price Target: $25
Current: $28.85
Upside: -13.34%
Oxford Nanopore Technologies plc
Mar 25, 2026
Maintained: Buy
Price Target: $1.7 → $1.72
Current: $129.40
Upside: -98.67%